FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
KFF Health News correspondent Rachana Pradhan discussed a lobbying effort to get Medicare to cover a new class of weight
Read MoreMolly Castle Work California’s largest public hospital plans to start notifying 43,000 former patients Monday that they may be eligible
Read More“How much is the ice cream?” A simple enough question, featured on a new TV and online advertisement, posed by
Read MoreA container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo Women’s
Read MoreIf you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline
Read MoreAs regulators review Kaiser Permanente’s proposed acquisition of a respected health system based in Pennsylvania, health care experts are still
Read MoreNorth Carolina hospitals — led by the state’s largest public medical system — have sued thousands of their patients since
Read MoreThe Biden administration wants to crack down on private arrangements among some hospitals to reimburse themselves for taxes that help
Read MoreTULSA, Okla. — When Lou Ellen Horwitz first learned that a gas station company was going to open a chain
Read MoreAugust 09, 2023 2 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read More